505 related articles for article (PubMed ID: 26291312)
21. MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines.
Terashima M; Tange S; Ishimura A; Suzuki T
J Biol Chem; 2017 Jan; 292(1):82-99. PubMed ID: 27852821
[TBL] [Abstract][Full Text] [Related]
22. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma.
Zhou M; Xu W; Yue X; Zhao H; Wang Z; Shi H; Cheng L; Sun J
Oncotarget; 2016 May; 7(20):29720-38. PubMed ID: 27105492
[TBL] [Abstract][Full Text] [Related]
23. LARRPM restricts lung adenocarcinoma progression and M2 macrophage polarization through epigenetically regulating LINC00240 and CSF1.
Li Y; Chen C; Liu HL; Zhang ZF; Wang CL
Cell Mol Biol Lett; 2022 Oct; 27(1):91. PubMed ID: 36221069
[TBL] [Abstract][Full Text] [Related]
24. Microarray profiling of differentially expressed lncRNAs and mRNAs in lung adenocarcinomas and bioinformatics analysis.
He F; Huang L; Xu Q; Xiong W; Liu S; Yang H; Lu W; Xiao R; Hu Z; Cai L
Cancer Med; 2020 Oct; 9(20):7717-7728. PubMed ID: 32869486
[TBL] [Abstract][Full Text] [Related]
25. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers.
Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ
J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162
[TBL] [Abstract][Full Text] [Related]
26. LncRNA Expression Signature in Prediction of the Prognosis of Lung Adenocarcinoma.
Li L; Feng T; Qu J; Feng N; Wang Y; Ma RN; Li X; Zheng ZJ; Yu H; Qian B
Genet Test Mol Biomarkers; 2018 Jan; 22(1):20-28. PubMed ID: 29297704
[TBL] [Abstract][Full Text] [Related]
27. LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2.
Han S; Cao D; Sha J; Zhu X; Chen D
Mol Oncol; 2020 May; 14(5):1074-1088. PubMed ID: 31919993
[TBL] [Abstract][Full Text] [Related]
28. Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.
Wan L; Sun M; Liu GJ; Wei CC; Zhang EB; Kong R; Xu TP; Huang MD; Wang ZX
Mol Cancer Ther; 2016 May; 15(5):1082-94. PubMed ID: 26908628
[TBL] [Abstract][Full Text] [Related]
29. Bmi-1-shRNA inhibits the proliferation of lung adenocarcinoma cells by blocking the G1/S phase through decreasing cyclin D1 and increasing p21/p27 levels.
Zheng X; Wang Y; Liu B; Liu C; Liu D; Zhu J; Yang C; Yan J; Liao X; Meng X; Yang H
Nucleic Acid Ther; 2014 Jun; 24(3):210-6. PubMed ID: 24552182
[TBL] [Abstract][Full Text] [Related]
30. High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer.
Lv J; Qiu M; Xia W; Liu C; Xu Y; Wang J; Leng X; Huang S; Zhu R; Zhao M; Ji F; Xu L; Xu K; Yin R
J Exp Clin Cancer Res; 2016 May; 35():75. PubMed ID: 27154193
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 antisense RNA 1 recruits enhancer of zeste 2 polycomb repressive complex 2 subunit to promote the proliferation, migration and invasion of lung adenocarcinoma cells.
Liu J; Pan C; Lu R; Zhang S
Bioengineered; 2022 Mar; 13(3):7868-7880. PubMed ID: 35291911
[TBL] [Abstract][Full Text] [Related]
32. LncRNA CARD8-AS1 suppresses lung adenocarcinoma progression by enhancing TRIM25-mediated ubiquitination of TXNRD1.
Pan C; Wang Q; Wang H; Deng X; Chen L; Li Z
Carcinogenesis; 2024 May; 45(5):311-323. PubMed ID: 38153696
[TBL] [Abstract][Full Text] [Related]
33. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C
Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347
[TBL] [Abstract][Full Text] [Related]
34. SNHG6 functions as a competing endogenous RNA to regulate E2F7 expression by sponging miR-26a-5p in lung adenocarcinoma.
Liang R; Xiao G; Wang M; Li X; Li Y; Hui Z; Sun X; Qin S; Zhang B; Du N; Liu D; Ren H
Biomed Pharmacother; 2018 Nov; 107():1434-1446. PubMed ID: 30257360
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA expression profiles of lung adenocarcinoma ascertained by microarray analysis.
Xu G; Chen J; Pan Q; Huang K; Pan J; Zhang W; Chen J; Yu F; Zhou T; Wang Y
PLoS One; 2014; 9(8):e104044. PubMed ID: 25089627
[TBL] [Abstract][Full Text] [Related]
36. Long Noncoding RNA RGMB-AS1 Indicates a Poor Prognosis and Modulates Cell Proliferation, Migration and Invasion in Lung Adenocarcinoma.
Li P; Zhang G; Li J; Yang R; Chen S; Wu S; Zhang F; Bai Y; Zhao H; Wang Y; Dun S; Chen X; Sun Q; Zhao G
PLoS One; 2016; 11(3):e0150790. PubMed ID: 26950071
[TBL] [Abstract][Full Text] [Related]
37. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
Yan K; Tian J; Shi W; Xia H; Zhu Y
Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
[TBL] [Abstract][Full Text] [Related]
38. Low expression of LINC00982 and PRDM16 is associated with altered gene expression, damaged pathways and poor survival in lung adenocarcinoma.
Lv W; Yu X; Li W; Feng N; Feng T; Wang Y; Lin H; Qian B
Oncol Rep; 2018 Nov; 40(5):2698-2709. PubMed ID: 30132554
[TBL] [Abstract][Full Text] [Related]
39. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer.
Ma Z; Gu S; Song M; Yan C; Hui B; Ji H; Wang J; Zhang J; Wang K; Zhao Q
Mol Biosyst; 2017 Oct; 13(11):2350-2361. PubMed ID: 28933484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]